Skip to content

Home monitoring of possible complications using the Meu PICC app in people with a central catheter inserted in the arm and treated in a day hospital

Extra-hospital monitoring of complications by application Meu PICC in patients using peripherally inserted central catheter attended in a day hospital: randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10mcrfkq
Enrollment
Unknown
Registered
2025-07-30
Start date
2022-12-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Catheterization

Interventions

Experimental study in the form of a controlled and randomized clinical trial with two arms, conducted with adult patients using a peripherally inserted central catheter at home, comparing standard hea

Sponsors

Escola de Enfermagem da Universidade de São Paulo
Lead Sponsor
Escola de Enfermagem da Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age equal to or greater than 18 years; have a smartphone with camera and internet access with proficiency in its use; home use of peripherally inserted central catheter PICC for medication administration; follow-up at the day hospital of the referring institution; both genders

Exclusion criteria

Exclusion criteria: Referred or perceived psychiatric illness; reported or perceived cognitive or sensory impairment without caregiver; terminal illnesses (such as cancer with metastases); difficulty in communication; without a caregiver; patients without return to the day hospital

Design outcomes

Primary

MeasureTime frame
Global incidence of complications related to the use of peripherally inserted central catheter PICC was observed verified by calculating the incidence density from the ratio between the number of complications and the total number of catheter-days in the study group;Incidence of thrombosis related to the use of peripherally inserted central catheter PICC was observed verified by clinical signs such as axillary pain limb edema and discoloration confirmed by ultrasound considering the proportion in relation to the total number of catheter-days in the study group;Incidence of local infection at the insertion site of the peripherally inserted central catheter PICC was observed verified through observation of clinical signs such as pain redness local heat or discharge using the total number of catheter-days as parameter;Incidence of bloodstream infection associated with peripherally inserted central catheter PICC was observed verified through clinical criteria established by Anvisa and CDC including fever chills hypotension and confirmation by blood culture using the number of infections in relation to total catheter-days as parameter;Incidence of phlebitis in the study group was observed verified by calculating the incidence density based on the number of cases in relation to the total number of catheter-days;Incidence of mechanical complications such as partial or total catheter obstruction externalization rupture phlebitis bloodstream infection insertion site infection or other reasons for early removal of the peripherally inserted central catheter PICC was observed verified through the number of recorded complications in relation to the total number of catheter-days;Incidence of nonelective removals of the peripherally inserted central catheter PICC was observed verified by the proportion between the number of early removals and the total catheter-days in the study group

Secondary

MeasureTime frame
The usefulness of the received guidance was described by the patients verified through scoring from 1 to 10 and categorization of reports at the end of the study

Countries

Brazil

Contacts

Public ContactYusely Rubio Meneses

Escola de Enfermagem da Universidade de São Paulo

yunarume@gmail.com+56926265045

Outcome results

None listed

Source: REBEC (via WHO ICTRP)